skip to main content

GAMBARAN KEPATUHAN MINUM OBAT PENCEGAHAN MASSAL FILARIASIS (STUDI DI WILAYAH KERJA PUSKESMAS JETAK KABUPATEN SEMARANG

*Putri Ratna Sari  -  Mahasiswa Peminatan Epidemiologi Fakultas Kesehatan Masyarakat Universitas Diponegoro, Semarang, Indonesia
Praba Ginandjar scopus  -  Bagian Epidemiologi Fakultas Kesehatan Masyarakat Universitas Diponegoro, Semarang, Indonesia
Lintang Dian Saraswati scopus  -  Bagian Epidemiologi Fakultas Kesehatan Masyarakat Universitas Diponegoro, Semarang, Indonesia
Received: 11 Mar 2020; Published: 30 Jun 2020.

Citation Format:
Abstract
Coverage of filariasis’ Mass Drug Administration at Jetak Public Health Center in the second round of treatment decreased from 99.6% to 77.2%. This shows the decrease in community participation in joining the filariasis’ MDA. The purpose of this study is to describe drug compliance of filariasis’ MDA in the working area of Jetak Public Health Center, Semarang Regency. This research is a descriptive cross sectional study using the rapid survey method. The study population is the entire target population for the second round of filariasis’ MDA in 2018 in the working area of the Jetak Community Health Center, aged ≥ 18 years. The sample size is 210 respondents from 30 clusters determined through probability proportional to cluster size (PPS). The results showed that compliance to filariasis’ MDA in the working area of the Jetak Public Health Center in Semarang Regency was 78.6%. Characteristics of respondents who tend to be obedient in taking drugs are: respondents in the age group 26-45 years (82.6%), men (80.5%), graduated from junior high school (89.5%), working (81.5% ), have a good level of knowledge of filariasis (84.6%) and MDA (91.6%), have positive perceptions of susceptibility (84.9%), severity (84.0%), and benefits (90.4%), have negative perception of barriers (91.5%), received cadre support (91.7%) and social support (88.9%), and have experiences in side effects of the drugs in the first round (93.8%). Increased socialization is needed related to filariasis and MDA so that public compliance in filariasis’ MDA increases.
Fulltext View|Download
Keywords: Compliance; Mass Drug Administration; Filariasis; Health Belief Model
Funding: Diponegoro University, Faculty of Public Health, Department of Epidemiology and Tropical Disease

Article Metrics:

  1. Kastner RJ, Stone CM, Steinmann P, Tanner M, Tediosi F. What is needed to eradicate lymphatic filariasis? A model-based assessment on the impact of scaling up mass drug administration programs. PLoS Negl Trop Dis. 2015;9(10):1–16
  2. Wahyono TYM. Analisis epidemiologi deskriptif filariasis di Indonesia. In: Pangaribowo S, Tryadi A, Indah IS, editors. Buletin Jendela Epidemiologi. Jakarta: Pusat Data dan Informasi Kementrian Kesehatan RI; 2010. p. 9–14
  3. World Health Organization. Global programme to eliminate lymphatic filariasis: a manual for national elimination programmes. Geneva: World Health Organization; 2011. 1-100 p
  4. Departemen Kesehatan RI. Pedoman Penatalaksanaan Kasus Klinis Filariasis. Jakarta: Direktorat Jenderal Pemberantasan Penyakit dan Penyehatan Lingkungan; 2006
  5. Departemen Kesehatan RI. Pedoman Eliminasi Filariasis di Indonesia. Jakarta: Direktorat Jenderal Pemberantasan Penyakit dan Penyehatan Lingkungan; 2008
  6. Wahyudi BF, Pramestuti N. Kondisi filariasis pasca pengobatan massal di kelurahan Pabean kecamatan Pekalongan Utara kota Pekalongan. Balaba J Litbang Pengendali Penyakit Bersumber Binatang Banjarnegara. 2017;12(1):55–60
  7. Dinas Kesehatan Kabupaten Semarang. Profil kesehatan kabupaten Semarang tahun 2016. Kabupaten Semarang: Dinas Kesehatan Kabupaten Semarang; 2017
  8. Dinas Kesehatan Kabupaten Semarang. Rekapitulasi Capaian Pelaksanaan POPM Filariasis di Kabupaten Semarang Tahun 2017. Kabupaten Semarang; 2017
  9. Dinas Kesehatan Kabupaten Semarang. Rekapitulasi Capaian Pelaksanaan POPM Filariasis di Kabupaten Semarang Tahun 2018. Kabupaten Semarang; 2018
  10. Balai Besar Teknik Kesehatan Lingkungan dan Pengendalian Penyakit. Survei evaluasi cakupan POPM filariasis di kabupaten Semarang tahun 2018. Yogyakarta; 2018
  11. Liu LL. Medical adherence and aging: Social and cognitive perspectives. 1st ed. Park DC, Liu LL, editors. Washington DC: American Psychological Association; 2007. 311 p
  12. Mathieu E, Direny AN, Rochars MB De, Streit TG, Addiss DG, Patrick J. Participation in three consecutive mass drug administrations in. Trop Med Int Heal. 2006;11(6):862–8
  13. Cantey PT, Rao G, Rout J, Fox LM. Predictors of compliance with a mass drug administration programme for lymphatic filariasis in Orissa State , India 2008. Trop Med Int Heal. 2010;15(2):224–31
  14. Matud MP. Gender and Health. In: Gender differences in different context. London: Intech Open; 2017. p. 57–76
  15. Lusi I, Utami GT, Nauli FA. Hubungan antara tingkat pengetahuan dan sikap masyarakat tentang penyakit filariasis dengan tindakan masyarakat dalam pencegahan filariasis. J Online Mhs Progr Stud Ilmu Keperawatan Univ Riau. 2014;1(2):1–9
  16. Notoatmodjo S. Promosi kesehatan: teori dan aplikasi. Revisi. Jakarta: Rineka Cipta; 2010. 389 p
  17. Notoatmodjo S. Ilmu perilaku kesehatan. Jakarta: Rineka Cipta; 2010. 115 p
  18. Soedarto. Buku ajar parasitologi kedokteran. 1st ed. Jakarta: CV. Sagung Seto; 2011. 217-228 p
  19. Alamsyah A, Marlina T. Faktor-faktor yang berhubungan dengan cakupan menelan obat massal pencegah filariasis. J Endur. 2016;1(1):17–22
  20. Kementrian Kesehatan RI. Peraturan Menteri Kesehatan Nomor 94 Tahun 2014 tentang Penanggulangan Filariasis. Indonesia; 2014
  21. Astuti EP, Ipa M, Wahono T, Ruliansyah A. Analisis perilaku masyarakat terhadap kepatuhan minum obat filariasis di tiga desa kecamatan Majalaya kabupaten Bandung tahun 2013. Media Penelit dan Pengemb Kesehat. 2017;24(4):199–208
  22. Adhikari R, Sherchand J, Mishra S, Ranabhat K, Devkota P, Mishra D, et al. Factors Determining Non-compliance to Mass Drug Administration for Lymphatic Filariasis Elimination in Endemic Districts of Nepal. J Nepal Heal Res Counc. 2014;12(2):124–9
  23. Njomo DW, Amuyunzu-Nyamongo M, Magambo JK, Ngure PK, Njenga SM. Factors associated with the motivation of community drug distributors in the lymphatic Filariasis Elimination Programme in Kenya. South African J Epidemiol Infect [Internet]. 2012;27(2):66–70. Available from: https://www.tandfonline.com/doi/full/10.1080/10158782.2012.11441487
  24. Glanz K, Rimer B, Viswanath K. Health behavior and health education: theory, research, and practice. 4th ed. San Francisco: Jossey-Bass A Wiley Imprint; 2008. 590 p

Last update:

No citation recorded.

Last update:

No citation recorded.